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Abstract: Coronary artery graft surgery (CABG) using a cardiopulmonary bypass (CPB)
pump to allow for stopping the heart, commonly designated as “on pump CABG” or
ONCAB, requires complete anticoagulation and is associated with significant
postoperative anemia. In addition, a reduction in postoperative platelet counts is relatively
common in large part due to heightened activation of hemostatic pathways and platelet
consumption secondary to blood passing through the CPB circuit. It has been
demonstrated that both anemia and nadir platelet counts after ONCAB are associated
with the incidence and severity of postoperative acute kidney injury (AKI). Over the past
several years, techniques have been refined for performing CABG without CPB,
commonly designated as “off pump CABG” or simply OPCAB. This approach removes
the need for anticoagulation thus potentially reducing postoperative bleeding and anemia,
and negates the effect of CPB on platelet consumption. Whether OPCAB surgery
mitigates the severity of postoperative anemia and thrombocytopenia relative to ONCAB,
however, remains unclear. Furthermore, it remains unknown if the association between
nadir platelet counts and AKI evident in ONCAB patients is present following OPCAB.
The present study was designed to test the hypotheses that: a) nadir platelet counts and
hemoglobin values, as well as bleeding and transfusion requirements differ between
ONCAB and OPCAB surgeries; b) the postoperative recovery of platelet counts and
hemoglobin values is more protracted in ONCAB vs. OPCAB; and c) that hemostatic
derangements are more closely associated with postoperative AKI in ONCAB as
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compared to OPCAB surgeries.
Methods: With IRB approval, a retrospective study from a single institution was
conducted involving 634 adult patients undergoing elective OPCAB (n=255) or ONCAB
(n=379). Data were captured for demographics, medical history, surgical characteristics,
postoperative blood loss (defined as chest tube output in the first 48 hours), hemoglobin
levels and platelet counts, and blood product transfusions. Between groups, daily median,
postoperative nadir, and discharge values for hemoglobin and platelets were compared
with nadir counts defined as the median lowest in-hospital value measured over the first 5
postoperative days and at discharge. In addition, the incidence of frank
thrombocytopenia, defined as platelet values of < 74 x 109/dL, was compared along with
the administration of packed red blood cells (RBC), fresh frozen plasma (FFP) and
platelet suspensions. AKI was defined according to KDIGO criteria, whereby
postoperative serum creatinine rise >50% or 0.3 mg/dL was indicative of injury. The
incidence of AKI was then determined for the OPCAB and ONCAB groups, both as a
whole and when subdivided into the segment of each group that was thrombocytopenic.
Results: The ONCAB and OPCAB cohorts were similar in regard to age (67 + 10 vs 67
+ 10), and male/female distribution (80/20 vs 72/28). For both groups, the median nadir
platelet values were observed on the second postoperative day and were not different
(145K vs 142K, p =0.44). Similarly, the incidence of thrombocytopenia was the same
following both OPCAB and ONCAB (5.88% vs. 5.54%) surgeries. Median nadir
postoperative hemoglobin concentration in OPCAB patients was 10.10 mg/dl and
occurred on postoperative day 2. In ONCAB patients, the median nadir postoperative
hemoglobin concentration was not different (9.90 mg/dl, p = 0.95) but occurred on
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postoperative 4. There was no difference in postoperative bleeding measured by chest
tube output between ONCAB vs. OPCAB (892 + 421 mL vs. 850 + 441 mL, p = 0.24).
The incidence of red blood cell (RBC) transfusion was comparable between groups. In
contrast, both rates of FFP (ONCAB 20% vs. OPCAB 8%; p<0.001) as well as platelet
transfusion (ONCAB 35% vs. OPCAB 10%; p<0.001) were different. Overall the pattern
of postoperative platelet recovery was comparable, with both cohorts recovering beyond
baseline values by postoperative day 5. The overall incidence of postoperative AKI was
comparable between ONCAB vs. OPCAB [33.3% (n=126) and 34.5% (n = 88)]. Patients
(combined ONCAB and OPCAB) who developed severe thrombocytopenia (n=36) had a
higher rate of AKI as compared to those with normal platelet counts (55.6% vs. 32.4%;
p=0.004). Further, intragroup analysis (ONCAB only) demonstrated a higher incidence of
AKI in those with severe postoperative thrombocytopenia as compared to patients with
“normal” platelet counts [62% (n=13) vs. 32% (n = 113); p =<0.004]. However, the same
analysis of OPCAB patients showed no difference in the incidence of AKI [47% (n =7)
vs. 34% (n=81); p = 0.31] for severe thrombocytopenia vs. normal platelet counts.
Conclusion: Our findings demonstrate that contrary to the study hypotheses, ONCAB
and OPCAB surgeries are actually similar in regard to postoperative thrombocytopenia,
anemia, bleeding, red blood cell transfusion rates, and recovery patterns for hemoglobin
and platelets. Despite these similarities, there were higher rates of FFP and platelet
transfusions in the ONCAB group. Overall, the incidence of AKI was the same when
comparing the entirety of both groups. However, in the subgroup of patients with
postoperative thrombocytopenia, patients who underwent ONCAB had a markedly higher
rate of AKI.
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Introduction
In the United States, nearly 200,000 patients undergo coronary artery bypass graft
(CABG) procedures yearly for medically refractory coronary artery diesease.1 Such
coronary revascularization has traditionally been performed with use of an extracorporeal
apparatus named cardiopulmonary bypass (CPB)- allowing the heart to be arrested
pharmacologically with cardioplegia. This approach has been further characterized as
on-pump CABG or “ONCAB”; whereas, CABG performed without CPB (off-pump) is
termed “OPCAB”.
Most complex cardiac surgical procedures require use of CPB. Employing this
approach offers many advantages such as providing a bloodless field via diversion of
blood to the CPB circuit, i.e., bypassing the heart. On the other hand, it also introduces
several physiologic, metabolic, and hematologic derangements that influence morbidity
and mortality.2,3 For example, hemodilution, consumption of coagulation factors and
fibrinogen, and platelet abnormalities can potentiate bleeding and anemia that, in turn,
would necessitate transfusion of blood products.4,5 Contact activation between blood and
the extracorporeal material also triggers significant cellular and inflammatory responses
and ischemia-reperfusion injuries, which have systemic effects including acute end-organ
failure such as acute kidney injury (AKI).6 Moreover, cardiac surgery including OPCAB
can generate microemboli arising from intracardiac sources and from aortic atheromatous
placques.7 Microaggregates formed from activated leukocytes and activated platelets may
be pivotal in the pathogenesis of postoperative stroke, acute respiratory failure, and AKI.8
The coagulation factors, platelets, fibrinogen, and leukocytes are not only exposed to the
non-biologic surface of the machine, but must endure the sheering forces of the CBP
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machine.7,9 This may lead to release of cytokines that promote further microthrombi,
exacerbating thrombocytopenia.10
In order to mitigate CPB associated complications, cardiac surgeons may opt to
perform OPCAB. Development of cardiac stabilizers has made it possible to conduct
CABG surgery on a beating heart and thereby avoid cardiac arrest and CPB. Ascione et
al. found that OPCAB is associated with a significant reduction in inflammatory response
and postoperative infection when compared with conventional revascularization with
ONCAB.11 OPCAB, however, is technically more challenging. Nevertheless, in a
retrospective review of the STS National Adult Cardiac Database, Polomsky et al.
analyzed 876,081 patients who underwent CABG between January 1, 2005 and
December 31, 2010.12 They concluded that OPCAB was associated with reduced risk of
death, stroke, acute renal failure, mortality or morbidity, and prolonged length of stay
compared with ONCAB.12 In contrast, Schopka et al. conducted a matched-pair analysis
of 1428 patients undergoing CABG.13 The patients were further stratified according to
their preoperative renal function, as ascertained from glomerular filtration rate (GFR) and
to risk of postoperative AKI. They concluded that use of CPB or its duration did not
increase risk or severity of postoperative AKI.13 Thus, there remains on going
controversies and inconclusive information regarding incremental benefits of OPCAB
over ONCAB. It is also uncertain whether OPCAB offers advantage over ONCAB with
regards to hemostatic derangements (thrombocytopenia, anemia, bleeding, and
transfusion requirements). At our Institution, OPCAB surgery is performed by one
surgeon, whereas, several surgeons perform ONCAB. This unique environment, allowed
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us to design a retrospective study investigating aforementioned hematologic changes in
ONCAB vs. OPCAB.

Primary Aim: To compare hemostatic derangements (thrombocytopenia, anemia,
bleeding, transfusions) between ONCAB vs. OPCAB surgeries
Secondary Aim: (1) To compare and characterize postoperative patterns of recovery of
both thrombocytopenia and anemia in ONCAB vs. OPCAB surgeries (2) and to
investigate whether hemostatic derangements in ONCAB and in OPCAB surgeries relate
to postoperative AKI.
•

We hypothesize that hemostatic responses (nadir platelet counts, nadir hemoglobin
values, bleeding, and transfusion requirements) will differ in ONCAB vs. OPCAB
surgeries.

•

We also hypothesize that the postoperative pattern of recovery of nadir platelet
counts and of nadir hemoglobin values will be significantly more protracted in
ONCAB vs. OPCAB.

•

Lastly, we hypothesize that hemostatic derangements will be significantly
associated with postoperative AKI in ONCAB as compared to OPCAB surgeries.
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Methods
Approval by the Institutional Review Board for Clinical Investigations, Yale University
School of Medicine, New Haven, CT was obtained.

Data Collection and Measurements
The following data were retrospectively collected on 634 adult patients who
underwent non-emergent ONCAB or OPCAB surgeries at Yale New Haven Hospital,
New Haven, CT: age, gender, race and ethnicity, height, weight, blood pressure, history
of COPD, CVA, recent MI, CPB time, aortic cross clamp time, surgical course,
laboratory values (platelets, hemoglobin, chemistry profile), perioperative medications,
and clinical outcomes. Hemoglobin values, platelet counts, and serum creatinine data
were collected from time of patient admission to hospital discharge. Three independent
investigators (STK*1, MMM*, AN*) verified the data quality by performing regular
crosschecks for completeness and consistency between the data set assembled and the
information available from the electronic medical records. STK created a java program in
order to format data collection into an excel file.

Definitions
The primary aim involved comparison of “hemostatic derangements” that
included: baseline platelets, daily nadir platelet counts; baseline hemoglobin, nadir
hemoglobin values, postoperative bleeding (postoperative 48 hour chest tube outputs),
transfusions (red blood cells, fresh frozen plasma, cryoprecipitate, cell saved blood, and

1

MMM – Miriam Monteiro-Mascarenhas AN –Adambeke Nwozuzu
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platelets). Baseline laboratory values indicate preoperative measurements closest to the
date of surgery. Subsequent measurements were characterized as day of surgery (DOS),
postoperative day (POD) 1, 2, 3, etc., and day of discharge from the hospital (Discharge).
Nadir platelet counts was defined as the median of the lowest in-hospital values measured
for the first 7 postoperative days and at discharge. Also nadir hemoglobin value was
defined as the median of the lowest in-hospital values measure for the first 7 days
postoperatively and at discharge. Likewise, we also recorded perioperative creatinine
values and defined baseline creatinine as the preoperative closest to the date of surgery.
An algorithm was constructed to ensure consistency for recording baseline creatinine
values.
Acute kidney injury was defined according with the Kidney Disease Improving
Outcomes (KIDGO) guidelines. Briefly, KIDGO separates AKI into 3 stages. Stage 1a.
Serum creatinine increase of (≥0.3 mg/dl) within a 48 hr. interval; 1b- an increase of
creatinine levels of 1.5-1.9 times baseline recordings; stage 2 AKI as a serum creatinine
increase of >2.0–3.0-times baseline recordings; stage 3a AKI serum creatinine increase
of >3.0-times baseline recordings; and stage 3b as serum creatinine of (≥4.0 mg/dl) with
an acute increase of at least (0.5 mg/dl).
Lastly, severe thrombocytopenia was defined as platelet values < 74 x 109/dL
based on the lowest tertile median value from our study cohorts.
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Statistics
The Wilcoxon rank sum test was used for statistical analysis of hemoglobin and platelet
values. Hemoglobin, platelets, creatinine percent change was calculated by dividing the
patients baseline lab value into the patient’s daily lab value minus baseline lab value:
Percent Change =

Daily lab value – Baseline lab value
Baseline lab value

Absolute change was calculated by subtracting baseline lab value, from Daily lab value,
Absolute change =

Daily lab value – Baseline lab value

The means for these values for each group + 95% confidence upper and lower limits were
plotted against, postoperative day. T-test was used for the following comparisons
between ONCAB and OPCAB: demographics, clinical and surgical characteristics,
hemostatic responses (transfusion, bleeding), intraoperative, and postoperative
pharmacological therapy categories. Chi-square test was used to calculate rates of AKI.
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Results
In total, 634 patients were included in our retrospective study. The ONCAB
cohort consisted of 369 patients, while the OPCAB cohort consisted of 255 patients.
Demographic, medical, surgical characteristics are presented on table 1.

Perioperative Platelets Trajectory and Recovery
The median baseline, nadir, and discharge values for platelet counts were similar
in ONCAB vs. OPCAB and are shown in table 2. The median nadir platelet values were
observed on POD2 for both groups (145K vs. 142K, p =0.44). The pattern of daily
decline and recovery of platelet counts was also similar in ONCAB vs. OPCAB; albeit,
non-clinically significant differences were observed between the two cohorts. For
example, on POD3 and POD4, the median platelet counts were (156K vs. 163K, p =
<0.04 and 191K vs. 202K, p=0.035) for ONCAB vs. OPCAB, respectively. Figure 1
depicts postoperative platelet counts according to percent change and absolute change
from baseline platelet values. Overall, the incidence of thrombocytopenia was similar in
OPCAB vs. ONCAB (5.88% vs. 5.54%) surgeries.
Perioperative Anemia and Recovery
Median baseline, nadir, and discharge hemoglobin values are presented in table 3.
Overall, nadir postoperative hemoglobin concentration was 10.10 mg/dl and occurred on
POD2 in OPCAB patients; whereas, in ONCAB patients, the minimum median
postoperative hemoglobin concentration was 9.90 mg/dl- occurring on POD4. Using the
Wilcoxon rank sum test, there was a significant difference in median hemoglobin values
on POD4, POD5, and on day of discharge between groups (table 3).

Figure 2a and 2b
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summarize perioperative patterns of hemoglobin- depicting its percent and absolute
changes from baseline. Such patterns of hemoglobin decline was similar in ONCAB vs.
OPCAB. Further, our results show markedly protracted recovery of in-hospital anemia
for both groups.
Transfusion of Blood Products
Table 4 contains results on transfusion of blood component therapies- comparing
ONCAB and OPCAB surgeries. There was no significant difference in total volume of
blood products transfused between the two groups. That is, among those patients
transfused in ONCAB and in OPCAB, average total volumes of RBCs, FFP, platelets,
cryoprecipitate, and cell saved blood were similar. Of interest, the incidence of RBC
transfusion was also comparable. In contrast, both rates of FFP (20% vs. 8%; p<0.001)
and platelets transfusion (35% vs. 10%; p<0.001) were significantly greater in ONCAB
vs. OPCAB.
Postoperative Acute Kidney Injury
Using the KDIGO criteria for AKI, the overall incidence of postoperative AKI
was comparable between ONCAB vs. OPCAB [33.3% (n=126) and 34.5% (n = 88)]. In
both groups, the majority of patients experienced stage I AKI [ONCAB (91%) vs
OPCAB (83.3%)]; stages II (0% vs. 7%), and stage III (9% vs. 11%).
Consistent with our prior work, we investigated the influence of platelets on
postoperative AKI. Whereas the incidence of severe thrombocytopenia was similar in
ONCAB vs OPCAB, patients (combined ONCAB and OPCAB) who developed severe
thrombocytopenia (n=36) had a higher rate of AKI as compared to those with normal
platelet counts (55.6% vs. 32.4%; p=0.004). Further, intragroup analysis (ONCAB only)
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demonstrated a significantly higher incidence of AKI in those with severe postoperative
thrombocytopenia [62% (n=13) vs. 32% (n = 113); p =<0.004] as compared to patients
with “normal” platelet counts. The same analysis was conducted in OPCAB patient
showing a non-significant incidence of AKI (47% vs. 34%; p = 0.31) for severe
thrombocytopenia vs. normal platelet counts.
Postoperative Bleeding
Postoperative bleeding was evaluated by total chest tube outputs and by
mediastinal re-exploration for bleeding. Overall chest tube outputs were unremarkable
between ONCAB and OPCAB (832 ± 364 mls vs. 940 ± 537 mls, p=0.05) and no
difference in re-exploration was observed.
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Discussion
The hematologic effects of either ONCAB or OPCAB remain poorly studied. As
such, based on available and relevant information, we surmised that compared to
OPCAB, CPB associated hematologic derangements in ONCAB surgery would have a
more profound effect on postoperative platelet counts, anemia, bleeding, and transfusion
requirements. Also, based on our previous work linking thrombocytopenia to
postoperative AKI in ONCAB surgery, we designed the current study to investigate the
relation between postoperative platelets and AKI in ONCAB and in OPCAB.
Our findings are intriguing as both ONCAB and OPCAB surgeries resulted in
similar and significant postoperative reduction from baseline values for platelets and for
hemoglobin. Further, rates of severe thrombocytopenia, volume of chest tube outputs,
incidence of AKI, and transfusion of RBCs were comparable in ONCAB vs. OPCAB.
We did observe a near two-fold increase in transfusion rate for FFP and a near three-fold
higher rate for platelets transfusion in the ONCAB vs. OPCAB procedure.

Perioperative Platelets and Clinical Implications in CABG Surgery
Platelet activation during cardiac surgery is well recognized, and several studies
have shown its role in perioperative stroke and myocardial infarction.14 During and after
CPB, complex pathophysiologic processes in both humoral and cellular processes occur
that involve coagulation factors, platelets, fibrinogen, vascular endothelium, and
leukocytes, which may promote a shift in risks from bleeding toward
microthrombosis.15,16 In certain perioperative conditions, a transition zone between
bleeding-related and thrombosis-promoting coagulopathy is likely present; while in other
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settings, bleeding and microthrombosis can occur concurrently, as observed in
disseminated intravascular coagulation.17
Nevertheless, CPB has also been shown to promote formation of microemboli
consisting of fibrin, activated leukocytes, and aggregated platelets. In addition, recent
evidence supports the role of platelets15,16 in defining endothelial responses and
neutrophil recruitment in ischemia/reperfusion injury including distant organ injury18 and
postischemic renal failure.19 It is noteworthy that thrombocytopenia is one of the most
common laboratory abnormalities in critically ill patients, and has been attributed in this
setting to increased platelet destruction (immune and non-immune), hemodilution,
platelet sequestration, or decreased production.20,21 Importantly, such thrombocytopenia
is closely associated with prolonged ICU length of stay, reduced survival and increased
incidence of AKI.22,23
We recently reported a significant association between postoperative nadir
platelet counts and postoperative AKI.8 The magnitude of decrease in platelet counts
correlated significantly with the severity of kidney injury, as well as short-term
mortality.8 While a significant drop in platelet counts is prevalent after CPB, the
implication of this finding has not been comprehensively examined in a cardiac surgical
patients undergoing OPCAB surgery. Our findings are novel as the pattern of reduction
in platelet counts and its postoperative recovery in ONCAB was very similar OPCABsuggesting that CABG surgery itself- irrespective of CPB- causes profound effects on
platelet activation and consumption. These findings were unexpected as conventional
teaching and thinking would support a greater CPB-associated quantitative and
qualitative platelet derangement as compared to OPCAB. Our findings also challenge
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conventional views on bleeding risks in ONCAP vs. OPCAB. It is opined that together
with platelet abnormalities, hemodilution, and marked reduction of coagulation factors
and fibrinogen would increase bleeding in ONCAB vs. OPCAB. Based on chest tube
outputs, we could not demonstrate a difference in bleeding between the two cohorts. We
found similar transfusion rate of RBCs- also raising an important question regarding preexisting clinical beliefs about hematologic effects of CPB in relation to major vascular
surgery without use of CPB. Nevertheless, we acknowledge that effects of CPB on
platelet counts cannot be overlooked as our study found thrice the rate of platelets
transfusion in ONCAB vs OPCAB. Giving the retrospective design of our study; lack of
a protocol-guided transfusion practice; and qualitative assessment of platelet function, it
remains uncertain whether transfusion of platelets and FFP were driven by subjective vs.
objective factors.
Consistent with our previous report, postoperative thrombocytopenia was
associated with AKI. Overall, compared to patients with normal platelet counts, the
presence of postoperative severe thrombocytopenia significantly increased the rate of
AKI (56% vs. 34%). Importantly, when we analyze severe thrombocytopenia (platelet
counts <75K) as a predictor of AKI, we also found a significant association in ONCAB
patients but not in OPCAB (47% vs. 34%, p=0.31). This is likely because of the small
sample size of patients with severe thrombocytopenia (n= 15) in the OPCAB cohort. Our
rationale for exploring AKI in patients in the lowest tertile is because this level of
thrombocytopenia (platelet counts <75) reflects a clinically important threshold of
platelet counts. Further, this approach should be a less arbitrary threshold for defining
thrombocytopenia (i.e. platelet counts < 100K) as is commonly chosen in some studies.
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In the OPCAB cohort, the incidence of AKI in thrombocytopenic patients was also much
higher than in patients with normal platelet counts

Postoperative Anemia and Recovery in ONCAB vs. OPCAB
We demonstrated that the magnitude of anemia after surgery and its recovery was
similar in OPCAB as observed in ONCAB. This finding also differs from our hypothesis
as we surmised that CPB-associated consumptive processes, hemodilution, and bleeding
would result in a more profound anemia, greater RBC transfusion and a slower recovery
of anemia as compared to the OPCAB approach. Thus, these findings raise many
questions regarding hemostatic effects of CABG surgeries and their management. Are
anesthesiologists, cardiac surgeons, and intensivist less restrictive with fluid
administration in OPCAB vs. ONCAB? Does OPCAB surgery have similar consumptive
and damaging effects on RBCs as seen in ONCAB? Should there be similar transfusion
triggers in OPCAB as in ONCAB?

Limitations
Because data was not acquired prospectively, there are two instances of potential
human errors. First, when clinical information was first documented into medical
records. Second, when the information was retrieved from medical records. Thirdly, all
of the information was acquired from electronic medical records; therefore, several
missing data points could not be retrieved.
Our study was conducted at a single tertiary medical center. This fact limits the
applicability of our results to study populations at other centers. Nevertheless, we had
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sufficient data on perioperative hematologic factors (platelets, hemoglobin, creatinine,
chest tube outputs, and specific transfusion therapies)- allowing for relevant and adequate
comparisons of predictor and outcome variables between ONCAB and OPCAB patients.
Lastly, we are not able to provide causes of postoperative anemia and
thrombocytopenia or a more precise mechanism of platelet associated AKI.

Conclusion
Our study reveals that ONCAB and OPCAB surgeries are associated with similar
hematologic effects such as postoperative thrombocytopenia, anemia, transfusion rates of
RBCs, chest tube outputs, and incidence of AKI. We also observe higher rates of FFP
and platelets transfusion in the ONCAB group. Lastly, patterns of postoperative recovery
of both platelet counts and anemia were similarly protracted in both ONCAB and
OPCAB. Future studies on mechanisms of hematologic derangements in OPCAB
surgery are warranted.
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Table 1: Demographics, Medical History, Laboratory Values, and Acute Kidney Injury

Age
Male
Female
COPD
PVD
CVA
Diabetes
b

Creatinine Baseline
Platelets Baseline
Hemoglobin Baseline
Acute Kidney Injury

OPCAB (N = 253) ONCAB (N =376)
67.38 (9.97)
67.29 (9.53)
182 (71.94%)
298 (79.26%)
71 (28.06%)
78 (20.74%)
Medical History
31 (12%)
62 (16.5%)
42 (17%)
40 (11%)
14 (5.5%)
28 (7.5%)
103 (40.7%)
153(40.7%)
Preoperative laboratory Values
1.15 ± (0.78)
1.15 ± (0.56)

P Values
0.94

209.00± (80)
218.50± (73)
13.60± (1.8)
13.25± (1.9)
Post operative clinical events
088 (34.51%)
126 (33.25%)

0.97
0.1505

0.14
0.029
0.35
1.00
0.99

0.74
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Table 2. Perioperative Platelet Counts in ONCAB vs. OPCAB
OPCAB

ONCAB

Median

min

max

median

min

max

P value

Baseline

209

121

609

219

120

790

0.05

Nadir

139

83

380

132

81

357

0.14

Discharge

233

92

662

215

104

616

0.055
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Table 3. Perioperative Hemoglobin Values in ONCAB vs. OPCAB
OPCAB

ONCAB

median

min

max

median

min

max

P value

Baseline

13.6

7.9

17.5

13.3

7.2

18.2

0.15

Nadir

9.40

7.9

14.6

9.50

7.2

17.2

0.95

Discharge

10.60

7.9

15.4

10.30

7.2

19.3

.002

[Type here]

5

[Type here]

Table 4: Transfusion Patterns in ONCAB and OPCAB Surgeries
OPCAB (n=255)

ONCAB (n = 379)

P-value
0.45

Red Blood Cells

079 (31%)

129 (34%)

Fresh frozen plasma

020 (8%)

0069 (18.6%)

<0.001

Platelets

025 (10%)

131 (35%)

<0.001

Cryoprecipitateá

005 (2%)

008 (2%)

0.91

0204 (81%)

318 (85%)

0.22
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Perioperative platelet counts profile and recovery. 1a (left) depict % change in
platelet counts and figure 1b representing absolute changes in platelets from
baseline. Note, similar trajectories in decline and postoperative recovery of platelet
counts were observed in both groups. Further, nadir platelet counts was noted on
postoperative day 2 in ONCAB and in OPCAB surgeries.
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Figure 2A

Figure 2B
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Perioperative hemoglobin values and recovery. 1a (left) depicts % change in hemoglobin and
figure 1b representing absolute changes in hemoglobin from baseline. Note, similar
trajectories in both decline in hemoglobin and postoperative recovery of anemia were observed
in both groups. Further, nadir hemoglobin values were noted on postoperative day 2 for
OPCAB and on POD4 for ONCAB surgery. Importantly, recovery from anemia was
protracted and markedly incomplete at time of discharge.

